Table 4.
Association between serum potassium variability and risk of mortality in all study population.
| CVSP | N patients (%) | HR (95%, CI), All-cause mortality | HR (95%, CI), Cardiovascular mortality | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Unadjusted | p-value | Adjusted | p-value | Unadjusted | p-value | Adjusted | p-value | ||
| L-CVSP | 439 (75.7%) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | ||||
| M-CVSP | 105 (17.9%) | 1.50 (0.96, 2.35) | 0.08 | 1.10 (0.69, 1.75) | 0.70 | 1.13 (0.52, 2.43) | 0.76 | 1.01 (0.46, 2.26) | 0.97 |
| H-CVSP | 44 (7.5%) | 2.79 (1.55, 5.03) | < 0.01 | 2.17 (1.18, 3.97) | < 0.05 | 3.03 (1.27, 7.24) | < 0.05 | 2.53 (1.03, 6.22) | < 0.05 |
HR hazard ratio.